This is the lay version of the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis using synthetic and biologic disease-modifying antirheumatic drugs. The original publication can be downloaded from the EULAR website: www.eular.org. Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic […]
Category: Rheumatoid arthritis
Tapering sequence does not affect costs
Slowly reducing medicines for people in remission can save money INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. When people reach sustained remission (no signs or symptoms of […]
There are still gaps in standards of care of people with rheumatoid arthritis
More work needs to be done to make sure EULAR standards of care are used across Europe INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. In 2008, the […]
People with early RA have signs of cardiovascular changes
Treatments for rheumatoid arthritis might also help to reduce cardiovascular damage INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. People with rheumatoid arthritis have an increased risk of […]
Economic status, location, and healthcare system impact how well treatments work in trials
More consistent reporting of patient characteristics is needed across rheumatology trials. INTRODUCTION Rheumatic diseases affect people’s joints, bones, tendons, ligaments and muscles – and often also other organs. Many of these diseases are autoimmune conditions that cause inflammation in the body. There are more than 200 rheumatic diseases, including rheumatoid arthritis, osteoarthritis, psoriatic arthritis, spondyloarthritis, […]
Managing RA with DMARDs
This is the lay version of the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis using synthetic and biologic disease-modifying antirheumatic drugs. The original publication can be downloaded from the EULAR website: www.eular.org. Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic […]
Changes may be needed to improve the usefulness of remission definitions
Adapting the thresholds in the Boolean remission definition would improve patient evaluation. Introduction Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. The goal of treatment for rheumatoid arthritis is […]
T2T in real-life helps people get to remission
Rheumatologists should follow a T2T-strategy in patients with both early and established rheumatoid arthritis. Introduction Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. ‘Treat to target’ (often shortened to […]
Unclear benefit of Zostavax in people starting on tofacitinib
Zostavax may not provide adequate long-term protection in people taking tofacitinib for their rheumatoid arthritis. Introduction Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. People with rheumatoid arthritis naturally […]
Success of infliximab discontinuation depends on disease activity at the start of treatment
This tailored treatment strategy did not statistically increase sustained remission after 1 year discontinuation. Introduction Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and possible disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. Treatments for rheumatoid arthritis aim to improve symptoms […]
